Pacer Advisors, Inc. Vericel Corp Transaction History
Pacer Advisors, Inc.
- $38.6 Billion
- Q1 2024
A detailed history of Pacer Advisors, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 805 shares of VCEL stock, worth $36,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
805Holding current value
$36,281% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding VCEL
# of Institutions
263Shares Held
48.9MCall Options Held
150KPut Options Held
128K-
Black Rock Inc. New York, NY7.97MShares$359 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.95MShares$223 Million4.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$154 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$145 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.33MShares$105 Million1.77% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.13B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...